ArticleNature communications2025

Interleukin-12 anchored drug conjugate (tolododekin alfa) in patients with advanced solid tumors: first-in-human Phase 1 trial.

Jong Chul Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.